MTOR and glomerulosclerosis: To evaluate whether mTOR inhibition can attenuate the progression of glomerulosclerosis in a later phase of disease development, we performed an experiment treating anti-Thy1.1 mice daily with sirolimus or phosal for a period of 20 days.